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Background: Oxidative stress and angiogenesis are important elements in the
pathogenesis of inflammatory diseases and cancer. Our aim was to evaluate the role
of both and of antioxidant capacity in the metaplasia-dysplasia-adenocarcinoma
sequence in Barrett epithelium.
Methods: In mucosal specimens from 59 patients grouped as having symptomatic
gastroesophageal reflux disease, Barrett epithelium, or adenocarcinoma in the
esophagus, plus controls, we measured myeloperoxidase activity, superoxidase
dismutase activity, glutathione content, and total aromatic DNA adducts. To eval-
uate blood vessel densities and angioarchitecture, we used immunohistochemistry
and a modified whole-mount technique. Sections were stained with endothelium-
specific markers and smooth muscle cell actin.
Results: The reflux disease–metaplasia-carcinoma sequence revealed progressively
increased oxidative stress (increased myeloperoxidase activity), decreased antioxi-
dant capacity (glutathione content), and simultaneous formation of DNA adducts.
Pooled data show a negative correlation between glutathione content and DNA
adducts (0.28; P  .05). This sequence was also characterized by increased
intensity in microvessels and an increasing percentage of immature blood vessels. In
addition, the whole-mount technique offered 3-dimensional evidence that the rich
new vascular bed is highly abnormal, with repeated twists, bends, or turns, even in
nonmalignant Barrett esophagus.
Conclusions: Increased oxidative stress, decreased antioxidant capacity, and a
negative correlation between glutathione content and DNA adduct formation indi-
cate a link between oxidative stress and malignant transformation of Barrett epi-
thelium. Simultaneously, this transformation acquires angiogenic capacity, strong
neovascularization, and abnormal angioarchitecture.
Barrett esophagus is a complication of gastroesophageal reflux dis-ease (GERD). This specialized intestinal metaplasia is consideredto be a premalignant condition for esophageal adenocarcinoma,which is rapidly increasing in incidence.1-3 Although its directmorphological sequence from metaplasia via dysplasia to cancer isrecognizable, the exact pathomechanism of this malignant trans-
formation is unknown.4 A driving force may, however, be oxidative stress.5,6
Oxidative stress stimulates angiogenesis in cultured endothelial cells.7 Endothe-
lial cell proliferation and microvascular remodeling occur at an early stage in
chronic inflammation,8 providing metabolic support for the tissues and allowing
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inflammatory cells to reach the diseased area. In several
organs, chronic inflammation has been associated with can-
cer.9-11 For their continuous growth beyond the diffusion
limit of oxygen, tumors must recruit new blood vessels,12
and such formation of new blood vessels from preexisting
ones—angiogenesis—occurs in chronic inflammation and
in tumor progression. In tumor cells, oxidative stress has
increased the production of angiogenic factors, interleu-
kin-8, and vascular endothelial growth factor.13 In the meta-
plasia-dysplasia-adenocarcinoma sequence in the esopha-
gus, potential factors stimulating angiogenesis are vascular
endothelial and fibroblast growth factors.14,15 Recently,
high vascularization was disclosed in esophageal adenocar-
cinoma and the adjacent intestinal metaplasia.15,16
Potential modulators of angiogenic activity are oxygen
free radical scavengers.17,18 The glutathione (GSH) redox
system and superoxide dismutase (SOD) are each consid-
ered to play a major role in the defense mechanism against
oxidative stress.19,20 SOD catalyzes superoxide to less toxic
compounds, and GSH serves as a substrate in reactions in
which electrophilic compounds, oxidants, and xenobiotics
are detoxified.20 GSH content and SOD levels are, in fact,
noticeably lower in Barrett epithelium than in normal
esophageal mucosa.21,22
Because oxidative stress plays a role in the pathogenesis
of GERD and in blood vessel growth in tumors,22,23 it may
be related to the malignant transformation and angiogenesis
of Barrett esophagus. This hypothesis was studied in con-




This study included 59 white patients (Table 1): 14 had symptom-
atic reflux disease with pathologic 24-hour pH measurement (pH
4; 16.9%  9.2%), and 15 had Barrett esophagus with histolog-
ically observable intestinal metaplasia with goblet cells in the
tubular esophagus. All patients with Barrett esophagus had reflux
symptoms and a pathologic 24-hour pH measurement (pH 4;
30.8%  20.4%). Of the 59 patients, 21 had adenocarcinoma of
the distal esophagus or esophagogastric junction. Controls were 9
patients with neither symptoms nor endoscopic evidence of esoph-
ageal pathology. No statistically significant age differences existed
between the groups (Table 1). The Ethics Committee of Helsinki
University Hospital approved this protocol.
Tissue-Sample Collection
All samples were taken either at endoscopy, with biopsy forceps,
or during operation, from the resected specimen. Patients were told
to forego any acid-suppressive treatment for 2 weeks before the
sampling (proton pump inhibitors, H2-blockers, or others). In
Barrett and adenocarcinoma patients, the most evident area mac-
roscopically was sampled. In GERD patients in case of endoscopic
normal mucosa and in the control group, samples were taken 5 cm
above the esophagogastric junction. Tissue adjacent to the speci-
men for histopathologic examination was processed for nonhisto-
logical analysis. For analysis of oxidative metabolism and DNA
adducts, specimens were immediately frozen and stored at70°C;
for analysis of angiogenesis, on the day of collection, only resected
specimens were processed to provide enough tissue for the whole-
mount method. Only 15 surgical samples were thus provided for
this part of the study. Because of this, 7 of the 10 Barrett samples
were from patients with adenocarcinoma. Of the 13 normal esoph-
ageal squamous samples, 3 were obtained from Barrett patients
and 10 were from patients with adenocarcinoma.
Methods
Myeloperoxidase (MP) activity was determined by modification of
the method of Suzuki and colleagues.24 SOD activity and GSH
content were determined by the methods of Laihia and col-
leagues25 and of Saville,26 respectively.
To assess overall exposure to DNA-reactive agents, we mea-
sured by the 32P-postlabeling technique the total aromatic DNA
adducts detected in a Bio-Rad Image Analysis System (Bio-Rad
Laboratories, Hercules, Calif).27 Although the method detects a
range of DNA adducts, smoking, nitrosamines, and aromatic hy-
drocarbons, sources of adducts other than oxidative stress were not
evaluated. Average levels of DNA adducts are expressed as ad-
ducts/109 nucleotides.
Tissue sections of resection specimens were stained with he-
matoxylin-eosin (Sigma, St Louis, Mo), Alcian blue (BDH Labo-
ratory Supplies Pool, Dorset, United Kingdom), and neutral red
(Sigma) to assess tissue histology and to localize Barrett epitheli-
um–specific goblet cells and blood vessels. To quantify blood
vessel densities, paraffin-embedded sections were deparaffinized
and stained for monoclonal antibody EN4 (which recognizes the
endothelium-specific transmembrane protein CD31; Monosan,
Uden, the Netherlands). Blood vessels that stained positive for
human endothelium were quantified in 200 magnification micro-
scopic fields (Olympus BX, Tokyo, Japan), and average counts
were made of 9 fields rich in vasculature from the mucosa as well
as from the periphery of the submucosal tissue.
For 3-dimensional studies, a whole-mount method was adapted
from Ryan and associates.28 One- to 2-mm–thick whole-mount
sections were stained for endothelium-specific markers (PAL-E
and EN4) and smooth muscle cell actin (SMA). PAL-E (which
recognizes an undefined endothelial antigen present in microves-
sels, but not in arteries) and EN4 were purchased from Monosan
(Immunodiagnostics, Ha¨meenlinna, Finland). Horseradish peroxi-
dase–conjugated anti-SMA monoclonal antibodies were from
DAKO Corporation (Copenhagen, Denmark). Whole-mount sec-
tions were viewed and photographed at 10 magnification (Leica
MZFLIII microscope, Solms, Germany).
TABLE 1. Patient groups
Patient group n
Age, y, mean  SD
(range)
Control 9 50.1 16.6 (25-76)
Reflux disease 14 52.9 10.9 (27-66)
Barrett esophagus 15 53.6 9.2 (42-69)
Adenocarcinoma 21 57.9 13.4 (39-77)
Total 59 54.3 12.5 (25-77)
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Mean, minimum, maximum, and SD were provided as descriptive
statistics. GSH content, SOD and MP activities, and DNA adducts
were compared between the groups (GERD, Barrett metaplasia,
cancer, and control) by the Kruskal-Wallis test; pairwise compar-
isons were performed by the Mann-Whitney U test. Nonparametric
methods were applied because of nonnormalities in the data.
Associations between each of these variables between groups were
assessed with the Spearman correlation coefficient. All P values
were based on 2-sided tests. Statistical calculations were per-
formed with SPSS software (SPSS Inc, Chicago, Ill).
Results
In the GERD-metaplasia-adenocarcinoma sequence, GSH
content was progressively lower and MP activity was higher
than in controls. Only in Barrett mucosa did SOD activity
differ from control activity (P  .042). Concurrently, mean
DNA adduct levels were significantly higher than control
levels in all 3 groups. Although levels between groups did
not differ significantly, the level was highest in Barrett
epithelium (Table 2, Figure 1).
In the pooled data, Spearman correlation analyses be-
tween GSH contents and DNA adducts showed a negative
correlation (0.28; P  .05), but there was no correlation
between SOD or MP activity and DNA adduct levels.
Barrett mucosa was characterized by intense infiltration
of endothelium-specific protein CD31–positive angiogenic
blood vessels (Figure 2, D). Microvessel density doubled
(SD) in Barrett epithelium (82.7 57.8; P .05) and was
2- to 3-fold greater in advanced adenocarcinoma (117.5 
56.7; P  .002) than in normal esophageal mucosa (43.9 
28.5).
The whole-mount technique showed only a few blood
vessels penetrating into normal esophageal mucosa (Figure
2, A). In Barrett epithelium and in related dysplasia and
adenocarcinoma, new angiogenic microvessels infiltrated
the entire mucosa (Figure 2, B and D). The angioarchitec-
ture within Barrett epithelium featured new microvessels
that were very small and deformed, containing tortuousities,
corkscrew structures, blind ends, and abnormal branching
(Figure 2, B). In paraffin sections, an increasing percentage
of vessels were devoid of SMA in Barrett epithelium (5%),
dysplasia (25%), and adenocarcinoma (40%).
Discussion
Simultaneous formation of DNA adducts, increased oxida-
tive stress (increased MP activity), decreased antioxidant
capacity (reduced GSH content), and angiogenesis in the
GERD-metaplasia-adenocarcinoma sequence of Barrett
esophagus indicated the important role played by oxidative
stress in the pathogenesis and malignant transformation of
Barrett epithelium. In studies measuring free radicals by
means of chemiluminescence assay and either lipid peroxi-
dation or MP activity in patients with reflux esophagitis or
Barrett epithelium, GERD has been shown to increase the
production of oxygen free radicals in the esophageal muco-
sa.22,23 In rats, a novel antioxidant (DA-9601) reduced in a
dose-dependent manner reflux-related esophageal mucosal
damage and lipid peroxidation.29 Our study supports these
findings, and, in addition, the increase in DNA adducts
simultaneously with oxidative stress in complicated GERD
strengthens the credibility of a role for gastroesophageal
reflux in the pathogenesis of esophageal adenocarcinoma.








n 9 14 15 21
Glutathione (gsh) (nmol/mg protein)
Mean  SD 2.88  0.74 1.78  0.61 1.30  0.27 1.30  1.30
P value* .004 .001 .001
P value† .004 .007 .007
Superoxide dismutase (U/mg protein)
Mean  SD 0.122  0.028 0.097  0.044 0.222  0.149 0.236  0.309
P value* .130 .042 .204
P value† .130 .002 .037
Myeloperoxidase (mp) (U/mg protein)
Mean  SD 0.21  0.23 1.41  2.01 3.87  2.67 2.21  2.88
P value* .244 .002 .001
P value† .244 .016 .053
DNA adducts/109 nucleotides
Mean  SD 0.14  0.21 11.5  4.3 15.2  13.7 8.9  4.6
P value* .001 .001 .001
P value† .001 .423 .068
GERD, Gastroesophageal reflux disease.
*P values based on the Mann-Whitney U test (pairwise comparisons, group vs control).
†P values based on the Mann-Whitney U test (pairwise comparisons, group vs GERD).
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An epidemiological association also exists between a higher
intake of antioxidants and a decreased risk for esophageal
adenocarcinoma.30 Oxidative stress can therefore be con-
sidered one of the important driving forces for such carci-
nogenesis.
Accelerated angiogenesis, assessed by higher microves-
sel density in microscopic fields, appears in Barrett epithe-
lium and esophageal adenocarcinoma.15,16,31 In this study,
microvessel density was doubled in Barrett epithelium and
was 2- to 3-fold higher in advanced adenocarcinoma than in
normal esophageal mucosa. Furthermore, the whole-mount
technique provided 3-dimensional evidence that during the
early stage of tumor development in Barrett epithelium, the
rich, new vascular bed is already highly abnormal. Malig-
nant transformation of Barrett epithelium must, therefore,
be angiogenesis dependent. Simultaneous angiogenesis and
increases of MP activity in the GERD-metaplasia-adenocar-
cinoma sequence of Barrett esophagus suggest that oxida-
tive stress is a component of a pathway that leads to the
onset and process of angiogenesis in the esophageal mu-
cosa. This study provides, however, no direct evidence to
link oxidative stress with angiogenesis.
An onset and process of angiogenesis requires a change
in the local equilibrium between proangiogenic and antian-
giogenic factors.32,33 Oxidative stress, after causing nonle-
thal cell injury to cells, may initiate a cascade of signal
transduction that leads to a tissue-repair process and to
angiogenesis.34 Endothelial and inflammatory cells release
angiogenesis activators, such as vascular endothelial growth
factor, angiopoietin-1, fibroblast growth factor, and trans-
forming growth factor, in abundance.12 Among these po-
tential proangiogenic factors, matrix metalloproteinase, vas-
cular endothelial growth factor, transforming growth factor,
and fibroblast growth factor have been discovered in the
metaplasia-dysplasia-adenocarcinoma sequence of Barrett
esophagus.14,35,36
In an animal model, inhibition of oral carcinogenesis by
GSH was related to inhibition of tumor angiogenesis.17 In
this study, DNA adducts were already higher and GSH
levels lower in GERD than in controls, indicating the early
role of oxidative stress in reflux-related esophageal mucosal
damage. With further suppression of antioxidant capacity
(GSH) and with increased MP activity in esophagitis and in
Barrett epithelium, the mucosa is exposed to amplified
oxidative stress; a low content of GSH in Barrett epithelium
has indeed been evident.21 DNA adducts were highest dur-
ing carcinogenesis in metaplastic mucosa—as seen in pre-
neoplastic colonic polyps and in tumor-adjacent pancreatic
tissue37,38—and not in the final stage of cancer. This study’s
negative correlation between GSH content and DNA adduct
formation indicates that the low antioxidant capacity of the
esophageal mucosa leads to an increase in DNA adduct
formation and risk for carcinogenesis. At the same time, this
GERD-metaplasia-adenocarcinoma sequence was charac-
terized by increased frequency of highly abnormal mi-
crovessels. Hence, reflux-related oxidative stress seems to
deplete GSH and enhance cellular sensitivity to various
agents and the risk for angiogenesis.
Figure 1. Glutathione (GSH), superoxide dismutase (SOD), and myeloperoxidase (MP) in normal esophageal
mucosa (Co), GERD, Barrett epithelium (BE), and adenocarcinoma of the distal esophagus/esophagogastric junction
(Ca). SOD and MP are expressed as units per milligram of protein; GSH is expressed as nanomoles per milligram
of protein.
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In our study, the total activity of SOD was increased in
Barrett mucosa and in adenocarcinoma. Tissue levels of
SOD in Barrett mucosa decrease when associated with
severe reflux esophagitis but increase with mild esophagi-
tis.22 The inflammatory cytokines are able to induce SOD
protein expression to increase the ability of cells to confront
oxidative stress.39 In mice, overexpression of copper/zinc
SOD induced angiogenesis.18 Although this seems to be a
physiologic mechanism to initiate tissue repair, unbalanced
overexpression of SOD could place the metaplastic and
carcinoma cells under oxidative stress by increasing intra-
cellular H2O2.40 In the Fenton reaction, H2O2 is converted
to highly reactive hydroxyl radicals. In gastric cancer and in
esophageal squamous cell cancer, manganese SOD was
increased and copper/zinc SOD was decreased,41 suggesting
that in specific subtypes of SOD, total SOD activity may not
reveal significant changes. Further studies are needed to
determine the exact contribution of changes in the activities
of SOD subtypes and angiogenesis in the GERD-metapla-
sia-dysplasia-adenocarcinoma sequence of Barrett esopha-
gus.
All these results, taken together, suggest an interesting
functional interplay among oxidative stress, radical scaven-
gers, and neovascularization in Barrett mucosa.
We express our gratitude for the statistical analysis performed
by Juha Akkila and for the skillful technical and secretarial assis-
tance of Yvonne Sundstro¨m.
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Discussion
Dr Steven J. Mentzer (Boston, Mass). I have 1 question. In the
sense that to implicate myeloperoxidase and oxidative stress and
some of the angiogenic factors in carcinogenesis you imply a cause
and effect, isn’t it possible that you can have inflammation that
would be associated with these secondary effects that really has no
causal relationship to adenocarcinoma of the esophagus?
Dr Sihvo. Myeloperoxidase is shown to increase oxidative
stress by generating highly reactive species from hydrogen perox-
ide. So we think that this shows the increased oxidative stress in
these steps.
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